Oncoinvent (ONCIN) EGM 2026 summary

Opening remarks and agenda

• Chair welcomed shareholders and guests, proposed Hans Cappelen Arnesen as meeting chair, and outlined the agenda.

• Election of chair and co-signer of minutes approved; notice and agenda confirmed as distributed in accordance with regulations.

Specific resolutions to be voted on

• Approved a small share capital increase to facilitate a 100-to-1 reverse share split, aiming to avoid penny stock status and attract professional investors.

• Approved reduction of nominal share value from NOK 0.50 to NOK 0.25 to provide flexibility for future equity raises.

• Authorized the board to increase share capital for employee options, board RSUs/options, and general purposes.

Shareholder proposals specific to EGM

• Shareholders questioned the rationale for the 100-to-1 split and the choice of NOK 0.25 nominal value, seeking clarity on future capital raise flexibility.